Trial intelligence / Profile preview

Midodrine crossover study in symptomatic orthostatic hypotension

2012-005761-12Phase 4Completed

Sponsor
Takeda
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of midodrine in orthostatic hypotension (OH) (2 arms), sponsored by Takeda. Started Mar 2013; status: completed.

02

Drugs

midodrine
03

Conditions

orthostatic hypotension (OH)

Beyond the preview

Go deeper on 2012-005761-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005761-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call